Abstract

Schistosoma mansoni extracts have been found to possess an active anabolic pathway for nucleotide biosynthesis in which adenosine is cleaved to adenine followed by conversion of adenine to AMP via adenine phosphoribosyltransferase. A significant fraction of labeled adenosine was found to enter the nucleotide pool by this pathway; howeverm, most of the nucleoside was converted to nucleotides by a pathway which employs adenosine deaminase, purine nucleoside phosphorylase and hypoxanthine phosphoribosyltransferase enzymes. Formycin A has been found to be a potent blocker of adenosine cleavage when tested in worm extracts. Arabinosyl-6-mercaptopurine and 6-thioguanosine are inhibitors of worm adenosine deaminase, and formycin B and 6-thioguanosine were found to inhibit the purine nucleoside phosphorylase of this parasite. Combinations of arabinosyl-6-mercaptopurine with either formycin A or formycin B result in substantial blockage of adenosine utilization for nucleotide synthesis. These studies thus suggest that adenosine analogues in combination might be useful in vivo for the chemotherapy of schistosomiasis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call